Hantavirus Infections Completed Phase 2 Trials for Methylprednisolone (DB00959)

IndicationStatusPhase
DBCOND0031052 (Hantavirus Infections)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00128180Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary SyndromeTreatment